Irinotecan and colorectal cancer: the role of p53, VEGF-C and α-B-crystallin expression

被引：13
|
作者：
Weekes, Jessica [2 ,3 ]
Ho, Yik-Hong [2 ,3 ]
Sebesan, Sabe [4 ]
Ong, Kate [2 ,3 ]
Lam, Alfred King-Yin [1 ]
机构：
[1] Griffith Med Sch, Gold Coast, Qld 4222, Australia
[2] James Cook Univ, Surg Sch Med, Townsville, Qld 4811, Australia
[3] James Cook Univ, N Queensland Ctr Canc Res, Australian Inst Trop Med, Townsville, Qld 4811, Australia
[4] Townsville Hosp, Townsville, Qld 4811, Australia
来源：
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE | 2010年 / 25卷 / 07期
关键词：
Colorectal Cancer; Vascular Endothelial Growth Factor; Median Survival; Genetic Marker; Irinotecan;
D O I：
10.1007/s00384-009-0862-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：907 / 907
页数：1
相关论文
共 50 条
  • [31] P53 EXPRESSION IN COLORECTAL TUMORS
    PURDIE, CA
    OGRADY, J
    PIRIS, J
    WYLLIE, AH
    BIRD, CC
    AMERICAN JOURNAL OF PATHOLOGY, 1991, 138 (04): : 807 - 813
  • [32] P53 EXPRESSION IN COLORECTAL ADENOMAS
    KAKLAMANIS, L
    GATTER, KC
    MORTENSEN, N
    BAIGRIE, RJ
    HERYET, A
    LANE, DP
    HARRIS, AL
    AMERICAN JOURNAL OF PATHOLOGY, 1993, 142 (01): : 87 - 93
  • [33] Mutagen sensitivity and p53 expression in colorectal cancer in China
    Shao, L
    Lai, M
    Huang, Q
    POSTGRADUATE MEDICAL JOURNAL, 2001, 77 (913) : 713 - 716
  • [34] EXPRESSION AND CLINIC AND PROGNOSTIC SIGNIFICANCE OF PTEN, P53, VEGF AND CERB-B2 IN METASTATIC COLORECTAL CANCER TREATED WITH BEVACIZUMAB
    Kara, I. O.
    Erdogan, S.
    Erkisi, M.
    Doran, F.
    Sahin, B.
    Kara, B.
    ANNALS OF ONCOLOGY, 2010, 21 : 219 - 219
  • [35] p53 protein and prognosis in Dukes B colorectal cancer
    Gervaz, PA
    Bouzourene, H
    Cerottini, JP
    Benhattar, J
    Chaubert, P
    Saraga, E
    Bosman, F
    Givel, JC
    GASTROENTEROLOGY, 1999, 116 (04) : A410 - A410
  • [36] P53、VEGF和VEGF-C在胰腺癌中的表达及意义
    刘进
    薛新波
    华中科技大学学报(医学版), 2004, (04) : 472 - 474
  • [37] αB-crystallin: A novel p53-target gene required for p53-dependent apoptosis
    Watanabe, Gou
    Kato, Shunsuke
    Nakata, Hideyuki
    Ishida, Takanori
    Ohuchi, Noriaki
    Ishioka, Chikashi
    CANCER SCIENCE, 2009, 100 (12): : 2368 - 2375
  • [38] Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer
    Arriaga, J. M.
    Bravo, I. A.
    Bruno, L.
    Morales Bayo, S.
    Hannois, A.
    Sanchez Loria, F.
    Pairola, F.
    Huertas, E.
    Roberti, M. P.
    Rocca, Y. S.
    Aris, M.
    Barrio, M. M.
    Baffa Trasci, S.
    Levy, E. M.
    Mordoh, J.
    Bianchini, M.
    HUMAN PATHOLOGY, 2012, 43 (10) : 1695 - 1703
  • [39] Prognostic significance of VEGF-C immunohistochemical expression in colorectal cancer: A meta-analysis
    Zong, Shaoqi
    Li, Hongjia
    Shi, Qi
    Liu, Shanshan
    Li, Wen
    Hou, Fenggang
    CLINICA CHIMICA ACTA, 2016, 458 : 106 - 114
  • [40] P53 IN COLORECTAL-CANCER
    SCOTT, N
    SAGAR, P
    STEWART, J
    BLAIR, GE
    DIXON, MF
    QUIRKE, P
    JOURNAL OF PATHOLOGY, 1990, 161 (04): : A343 - A343
12345